These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 16231258

  • 1. Hepatitis B and liver transplantation.
    Tung BY, Kowdley KV.
    Clin Infect Dis; 2005 Nov 15; 41(10):1461-6. PubMed ID: 16231258
    [Abstract] [Full Text] [Related]

  • 2. Living donor liver transplantation for hepatitis B associated liver diseases: a 10-year experience in a single center.
    Ikegami T, Soejima Y, Ohta R, Taketomi A, Yoshizumi T, Harada N, Kayashima H, Maehara Y.
    Hepatogastroenterology; 2008 Nov 15; 55(85):1445-9. PubMed ID: 18795708
    [Abstract] [Full Text] [Related]

  • 3. Advances in prophylaxis and treatment of recurrent hepatitis B after liver transplantation.
    Wang ZF, Zhu ZJ, Shen ZY.
    Hepatobiliary Pancreat Dis Int; 2005 Nov 15; 4(4):509-14. PubMed ID: 16286253
    [Abstract] [Full Text] [Related]

  • 4. Management of hepatitis B in liver transplant recipients.
    Coffin CS, Terrault NA.
    J Viral Hepat; 2007 Nov 15; 14 Suppl 1():37-44. PubMed ID: 17958641
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Management of hepatitis B in liver transplant patients.
    Mohanty SR, Cotler SJ.
    J Clin Gastroenterol; 2005 Jan 15; 39(1):58-63. PubMed ID: 15599213
    [Abstract] [Full Text] [Related]

  • 7. Prophylaxis of recurrent hepatitis B in Chinese patients after liver transplantation using lamivudine combined with hepatitis B immune globulin according to the titer of antibody to hepatitis B surface antigen.
    Jiao ZY, Jiao Z.
    Transplant Proc; 2007 Jun 15; 39(5):1533-6. PubMed ID: 17580182
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Outcomes of hepatitis B virus recurrence after liver transplantation.
    Han YS, Lee SK, Joh JW, Kim SJ, Kwon CH, Park JW, Kim DJ, Park JB.
    Transplant Proc; 2006 Sep 15; 38(7):2123-4. PubMed ID: 16980019
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prophylaxis and treatment of recurrent viral hepatitis after liver transplantation.
    Riediger C, Berberat PO, Sauer P, Gotthardt D, Weiss KH, Mehrabi A, Merle U, Stremmel W, Encke J.
    Nephrol Dial Transplant; 2007 Sep 15; 22 Suppl 8():viii37-viii46. PubMed ID: 17890261
    [Abstract] [Full Text] [Related]

  • 17. Outcome of patients with hepatitis B virus and human immunodeficiency virus infections referred for liver transplantation.
    Terrault NA, Carter JT, Carlson L, Roland ME, Stock PG.
    Liver Transpl; 2006 May 15; 12(5):801-7. PubMed ID: 16628690
    [Abstract] [Full Text] [Related]

  • 18. Role of long-term lamivudine treatment of hepatitis B virus recurrence after liver transplantation.
    Woo HY, Choi JY, Jang JW, You CR, Bae SH, Yoon SK, Yang JM, Choi SW, Han NI, Kim DG.
    J Med Virol; 2008 Nov 15; 80(11):1891-9. PubMed ID: 18814257
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J, Rimola A, Laguno M, de Lazzari E, Rascón J, Agüero F, Blanco JL, Moitinho E, Moreno A, Miró JM, ESLD-HIV Working Group Investigators.
    Liver Transpl; 2009 Sep 15; 15(9):1133-41. PubMed ID: 19718643
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.